Mr Lars Paal Hasvold
AstraZeneca, Oslo (Norway)
Follow
Contributor content
Journal
Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study
16 August 2017
